16 January 2018

Meeting with Roche

When the groundbreaking results of the Huntingtin lowering trial was announced, the European Huntington Association travelled to Basel to meet […]

Continue Reading

22 December 2017

Christmas card from Roche

This December IONIS Pharmaceuticals announced their groundbreaking results from the first Huntingtin lowering trial in humans (called IONIS-HTTRx). At the […]

Continue Reading

11 December 2017

Groundbreaking results!

This date will probably go into history along with the discovery of the Huntington gene in 1993. Today IONIS Pharmaceuticals […]

Continue Reading

15 July 2017

Is everyone gone for the summer?

It is summer and all of a sudden it feels like the whole world stops for a second. It is […]

Continue Reading

8 July 2017

Summer news from the HD community

Three times a year the EHDN newsletter appears. Now you can read the summer edition; with latest news from the […]

Continue Reading

4 May 2017

Spring News from the research community

Three times a year the EHDN newsletter appears. Now you can read the Spring edition – with latest news from […]

Continue Reading

28 April 2017

Updates from an exciting conference!

24th of April marked the opening of the 12th CHDI conference in Malta. 27th marked the end. What have we learned? HDBuzz has […]

Continue Reading

27 April 2017

What is this new Huntington’s disease drug?

A scientific paper declared a while ago positive results for a trial of the drug deutetrabenazine in Huntington’s disease. The […]

Continue Reading

6 April 2017

New drug for HD approved in USA

Exciting news for the Huntington’s disease (HD) community! The USA drug regulator, the FDA, has approved a new drug in […]

Continue Reading

28 February 2017

Reflecting on HD as a rare disease – and why Enroll-HD is so important

February 28 was the  Rare Disease Day – the day of international recognition for the myriad of little known but […]

Continue Reading

Follow Us

  • Vimeo


  1. CHDI Therapeutics Conference

    February 26 - March 1

Funding Partners